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Abstract
Background: Augmentation index, a marker of central wave reflection, is influenced by age, sex, height, blood
pressure, heart rate, and arterial stiffness. However, the detailed haemodynamic determinants of augmentation
index, and their relations, remain uncertain. We examined the association of augmentation index with vascular
resistance and other haemodynamic and non-haemodynamic factors.
Methods: Background information, laboratory values, and haemodynamics of 488 subjects (239 men, 249 women)
without antihypertensive medication were obtained. Indices of central wave reflection, systemic vascular resistance,
cardiac function, and pulse wave velocity were measured using continuous radial pulse wave analysis and
whole-body impedance cardiography.
Results: In a regression model including only haemodynamic variables, augmentation index in males and female
subjects, respectively, was associated with systemic vascular resistance (β = 0.425, β = 0.336), pulse wave
velocity (β = 0.409, β = 0.400) (P < 0.001 for all), stroke volume (β = 0.256, β = 0.278) (P = 0.001 for both) and
heart rate (β = −0.150, β = −0.156) (P = 0.049 and P = 0.036). When age, height, weight, smoking habits, and
laboratory values were included in the regression model, the most significant explanatory variables for
augmentation index in males and females, respectively, were age (β = 0.577, β = 0.557) and systemic vascular
resistance (β = 0.437, β = 0.295) (P < 0.001 for all). In the final regression model, pulse wave velocity was not a
significant explanatory variable for augmentation index, probably due to the high correlation of this variable
with age (Spearman’s correlation ≥0.617).
Conclusion: Augmentation index is strongly associated with systemic vascular resistance in addition to arterial
stiffness.
Trial registration: ClinicalTrials.gov, NCT01742702.
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Background
Reflected pressure waves from the peripheral circulation,
originating from the arterial branches and resistance ar-
teries, augment central blood pressure (BP) at the aortic
root level [1]. Augmentation index (AIx), a widely used
marker of central wave reflection, is defined as a ratio
between augmentation pressure (contribution of the
reflected pressure wave to systolic pressure) and pulse
pressure. Ideally, AIx should be obtained at the central
level, i.e. at the site of the carotid artery or ascending
aorta [2]. AIx can be recorded non-invasively from the
carotid artery with an applanation tonometry device [3],
but is usually estimated from radial arterial tonometric
signal using a generalized transfer function [4]. Accord-
ing to some studies, an increase in AIx has predictive
value for future cardiovascular events and mortality
[5–7]. However, this was not seen in the Framingham
study, in which elevated pulse wave velocity (PWV),
an acknowledged marker of arterial stiffness [2], was
found to increase the risk of future cardiovascular
morbidity [8].
Despite intensive research in the field of central wave
reflection, the detailed determinants of AIx are still
under debate. Naturally, there is a strong correlation be-
tween AIx and BP. AIx has shown to be higher among
females when compared with males, and there is an in-
verse correlation between AIx and height [9, 10]. This
inverse correlation is considered to result from earlier
return of wave reflection in shorter subjects [10]. Age
has been repeatedly shown to be a strong determinant of
AIx [9, 11]. In addition, AIx has been reported to correlate
inversely with heart rate (HR), so that it falls on average
by 4 % for every 10 beats/min increase in HR [12].
Since central wave reflection is influenced by arterial
compliance, AIx is often referred to as a marker of arter-
ial stiffness [13–19]. However, according to expert con-
sensus documents, AIx is an indirect surrogate measure
of arterial stiffness that provides additional information
concerning central wave reflections [2, 20].
Systemic vascular resistance (SVR) is of foremost im-
portance in defining BP and haemodynamics, but this
variable is hardly ever determined in clinical practice
and seldom even in research settings [21]. Since the
reflected pressure waves from the peripheral circulation
significantly originate from the resistance arteries [1], it
seems likely that higher SVR would lead to a more
prominent wave reflection and higher AIx. Based on
experiments utilizing the vasodilator nitroglycerin, a
decrease in SVR has been considered to reduce AIx,
although SVR was not actually measured in the experi-
mental setting [22]. Actually, simultaneous evaluations of
SVR and AIx have rarely been performed [21, 23, 24], and
to our knowledge the association of AIx and SVR versus
PWV has not been compared.
Taken together, there are still several unanswered
questions regarding the determinants of AIx. In this
study, we compared the role of SVR versus PWV as
haemodynamic determinants of AIx by parallel measure-
ments of these variables in 488 subjects.
Methods
Study subjects
Subjects to this study on haemodynamics were recruited
from the University of Tampere, Tampere University
Hospital, occupational health care providers, and by the
use of two newspaper announcements (DYNAMIC-
study, clinical trial registration NCT01742702). Also,
people enrolling in a long-distance running program for
beginners at Varala Sports Institute were informed about
the study. The responding subjects from all of the above
sources were recruited. Both normotensive and hyper-
tensive individuals were allowed to participate. Before
acceptance to the present study, lifestyle habits, medical
history, and family history for cardiovascular disease
were documented. Exercise habits were recorded as the
number of self-reported ≥30 min exercise sessions per
week that caused shortness of breath or sweating. A
medical examination by a physician, and routine labora-
tory analyses of hypertension were performed [25]. By
the time of the present study, 688 subjects had partici-
pated in the recordings. Subjects with antihypertensive
medication, atrial fibrillation, or who had a history of
diabetes, coronary artery disease, stroke, valvular heart
disease or secondary hypertension were excluded from
the present study. Altogether 488 subjects were included
in this study.
Laboratory analyses
Blood samples were obtained after approximately 12 h
of fasting. A standard 12-lead electrocardiogram was re-
corded, and Cornell ECG voltage product was calculated.
Plasma sodium, potassium, calcium, glucose, creatinine,
cystatin-C, triglyceride, and total, high-density and low-
density lipoprotein (HDL and LDL, respectively) choles-
terol concentrations were determined by using Cobas
Integra 700/800 or Cobas6000, module c501 (Roche Diag-
nostics, Basel, Switzerland). Blood cell count was analysed
by ADVIA 120 or 2120 (Bayer Health Care, Tarrytown,
NY, USA). Since creatinine values were within normal
range, glomerular filtration rate was estimated using the
Rule formula [26].
Haemodynamic measurement protocol
Haemodynamics were recorded in a research laboratory
by trained nurses. Study subjects were instructed to
avoid caffeine containing products, smoking and heavy
meals for at least 4 h prior to the investigation, whereas
alcohol and heavy exercise were to be avoided for at
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least 24 h. Impedance cardiography electrodes were
placed on body surface, tonometric sensor for pulse
wave analysis on the radial pulsation to the left wrist,
and an oscillometric brachial cuff for BP calibration to
the right upper arm. The left arm (abducted to 90°) with
the tonometric sensor rested on the level of the heart in
an arm support [24]. The measurements were started
once a visually assessed positional equilibrium was
reached in the beat-to-beat measurement data. Haemo-
dynamic data was recorded continuously for 5 min with
the subjects in supine position.
Pulse wave analysis
Radial BP and pulse waveform were determined from
the radial pulsation by an automatic tonometric sensor
(Colin BP-508 T, Colin Medical Instruments Corp.,
USA), calibrated approximately every 2.5 min by contra-
lateral brachial systolic and diastolic BP measurements.
Before the actual haemodynamic recordings, BP was
measured manually 2 times by the use of an ordinary
sphygmomanometer to verify that the automated BP
readings are correct. Continuous aortic BP and wave re-
flections were derived from the radial tonometric signal
with the SphygmoCorR pulse wave monitoring system
(SphygmoCor PWMx, AtCor Medical, Australia) using
the previously validated generalized transfer function [4].
HR, aortic pulse pressure (aortic systolic pressure – aortic
diastolic pressure), aortic augmentation pressure and AIx
(aortic augmentation pressure/aortic pulse pressure ×
100 %) were determined.
Whole-body impedance cardiography
A whole-body impedance cardiography device (CircMonR,
JR Medical Ltd, Tallinn, Estonia), which records the
changes in body electrical impedance during cardiac cy-
cles, was used to determine beat-to-beat HR, stroke vol-
ume, cardiac output, and aortic-popliteal PWV [27]. The
mechanism of function, electrode placement, and process-
ing of impedance cardiography data have been previously
described [21, 27–29]. Briefly, the impedance cardiog-
raphy method calculates PWV between the level of the
aortic root and the popliteal artery by the use of the
whole-body impedance signal and the signal measured
from the popliteal artery region [27, 28]. The PWV results
obtained using CircMonR show good repeatability [29],
and normal values for PWV in 799 individuals (age 25–76
years) have been previously published [30]. We have also
shown that the determination of stroke volume using im-
pedance cardiography versus 3-dimensional echocardiog-
raphy show good correlation [29]. SVR was calculated
from the tonometric radial BP signal and cardiac output
measured by the CircMonR device by subtracting average
normal central venous pressure (4 mmHg) from mean ar-
terial pressure and dividing it by cardiac output. Mean
arterial pressure was calculated by using the formula:
[(systolic BP)/3 + 2 × (diastolic BP)/3]. Cardiac output,
stroke volume and SVR were indexed to body surface area
(abbreviated as CI, SVI and SVRI, respectively).
Whole-body impedance cardiography versus applanation
tonometry in the measurement of PWV
The impedance cardiography method has been shown to
agree well with Doppler ultrasound when assessing
aortic-popliteal PWV [27]. However, the recording of
aortic-popliteal PWV using impedance cardiography has
not been previously compared with the gold standard
method, tonometric carotid-femoral measurement of
PWV. To examine the potential differences resulting
from recordings in different large arterial segments (i.e.
aortic-popliteal vs. carotid-femoral) on PWV, a series of
recordings was performed to compare the measurements
of PWV using the impedance cardiography versus the
tonometric method in additional 80 volunteers. Cardiac
arrhythmias, diagnosis of heart failure, carotid artery
stenosis or valvular heart disease were used as exclusion
criteria in this sub-study. The beat-to-beat recording of
aortic-popliteal PWV using the CircMonR impedance
cardiography was carried out for one minute, and the
carotid-femoral PWV using the SphygmoCorR applana-
tion tonometry was measured at the end of the same mi-
nute of recording. A previously validated equation was
applied to adjust the PWV values obtained using imped-
ance cardiography [27, 29]. The measurements were
started once a visually assessed positional equilibrium
was reached in the beat-to-beat measurement data.
Statistical analyses
Mean values of the haemodynamic variables from the
3rd to the 5th minute of recording, when the signal was
most stable, were used in the analyses. To study the deter-
minants of AIx, linear regression analyses with backward
elimination were performed separately for males and
females because of the known difference in AIx between
sexes [9]. Potential variables for multiple linear regression
models were chosen after testing with univariate linear
regression. All variables with P < 0.1 in either sex were in-
cluded in the multivariate regression models. Although
weight did not reach this criterion, it was included because
of potential interrelation with several other variables. In the
first regression model only haemodynamic variables (SVRI,
PWV, HR, and SVI) were used as explanatory variables for
AIx (Table 3). In the second regression model SVR, PWV,
stroke volume, HR, age, height, weight, smoking (in pack
years, i.e. number of packs containing 20 cigarettes smoked
per day multiplied by years of smoking), plasma low-density
lipoprotein (LDL) cholesterol, triglyceride, cystatin-C and
fasting glucose concentrations were used as explanatory var-
iables (Table 4). As the correlation between AIx and PWV
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was not linear, the common logarithm of PWV was
used in the linear regression analyses. Coefficients (b)
and standardized coefficients (beta) of regression, and
Pearson’s correlations (r) were calculated. Spearman’s
correlation was calculated for the association between
AIx and PWV due to non-linearity.
In the PWV comparison study, each study subject’s
beat-to-beat PWV using whole-body impedance cardiog-
raphy during a one-minute period was recorded, and the
average PWV was calculated. This mean PWV value was
then compared with the PWV value measured using
applanation tonometry at the end of the same one-
minute period. Pearson’s correlation was calculated, and
the two methods were compared using the statistical
method of Bland and Altman [31].
Data were analysed using SPSS software version 17.0
(SPSS Inc., Chicago, Illinois, USA), presented as mean ±
SD, and p-values <0.05 were considered significant.
Table 1 Basic characteristics and laboratory values in males and females
Male SD Female SD P-value
n = 239 n = 249
Age (years) 46 11 45 12 0.498
Smoking (pack years) 3.4 9 1.3 6 0.002
Never (128 males, 157 females) - -
Current (29 males, 26 females) 6.6 11.92 6.0 13.9 0.645
Previous (82 males, 65 females) 7.5 12.25 2.4 7.1 <0.001
Exercise habits (number of self-reported ≥30 min exercise sessions per week) 3.0 1.8 3.3 1.8 0.056
Height (cm) 180 6 166 6 <0.001
Weight (kg) 90 13 72 14 <0.001
Body mass index (kg/m2) 27.6 4.1 25.9 4.6 <0.001
Office systolic blood pressure (mmHg) 146 22 134 20 <0.001
Office diastolic blood pressure (mmHg) 92 11 85 12 <0.001
Cornell ECG voltage product (ms*mm) 1694 620 1609 482 0.093
Fasting plasma glucose (mmol/l) 5.6 0.6 5.3 0.5 <0.001
LDL cholesterol (mmol/l) 3.2 1.0 2.7 0.9 <0.001
HDL cholesterol 1.36 0.34 1.78 0.42 <0.001
Triglycerides (mmol/l) 1.50 1.33 1.06 0.63 <0.001
Cystatin-C (mg/l) 0.85 0.15 0.77 0.13 <0.001
eGFR (ml/min/1.73 m2) 119 14 104 9 <0.001
Values presented as means and standard deviations (SD); LDL low density lipoprotein, HDL high density lipoprotein, eGFR, rule formula of estimated glomerular
filtration rate [28]
Table 2 Haemodynamic variables measured in the laboratory in males and females
Male SD Female SD P-value
n = 239 n = 249
Systolic blood pressure (mmHg) 138 18 127 19 <0.001
Diastolic blood pressure (mmHg) 80 13 74 13 <0.001
Heart rate (1/min) 62 9 64 9 0.012
Augmentation index (%) 18.5 11.3 26.6 11.4 <0.001
Augmentation pressure (mmHg) 8.4 5.9 11.9 6.8 <0.001
Pulse wave velocity (m/s) 9.03 2.15 8.03 1.69 <0.001
Systematic vascular resistance (dyn*s/cm5) 1289 283 1402 319 <0.001
Systematic vascular resistance index (dyn*s/cm5/m2) 2686 583 2507 602 0.001
Stroke volume (ml) 98.1 13.5 80.7 13.6 <0.001
Stroke volume index (ml/m2) 47.0 6.6 45.2 7.3 0.004
Cardiac index (1/min/min2) 2.92 0.50 2.89 0.50 0.543
Values presented as means and standard deviations (SD)
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Results
Subject characteristics and haemodynamics
The features of the study population (n = 488; 239 men
and 249 women) are summarized in Table 1. The ten
most common self-reported medical conditions were:
dyslipidaemia (n = 101), asthma (n = 25), hypothyroidism
(n = 17, all euthyroid), migraine (n = 15), gout (n = 14),
osteoarthritis (n = 11), gastro-oesophageal reflux (n = 9),
depression (n = 8), panic disorder (n = 5), and coeliac dis-
ease (n = 4). The majority of the subjects (n = 309/488)
were completely without medications (for specific study
subject medication details please see Additional file 1).
Altogether 88 subjects were using female hormones
(oestrogen, progestin or combination) for contraception
or hormone replacement therapy (n = 37 with per oral
tablets, n = 26 with levonorgestrel releasing intrauterine
device). Although 101 subjects reported a history of dysli-
pidaemia, only 11 were using lipid-lowering medication.
Since AIx is lower in males than females [9], the statis-
tics were performed and scatter plot images were depicted
separately for sexes. Apart from age, exercise habits and
Cornell ECG voltage product, there was a statistically sig-
nificant difference between males and females in every
variable (Table 1).
Both systolic and diastolic BP was higher in males than
females (Table 2). AIx and augmentation pressure were
Fig. 1 Associations between augmentation index and its known determinants. Scatter plots show associations between augmentation index and
age (a, b), height (c, d), and heart rate (e, f) in male and female subjects, the lines depict mean and 95 % confidence intervals of mean
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higher in females (p < 0.001 for both), whereas PWV
(p < 0.001) and SVRI (p = 0.001) were higher in males.
Apart from CI, all haemodynamic variables showed
significant differences between the sexes (Table 2).
Correlations between AIx and other variables
The association between AIx and age was very clear
(Fig. 1a, b), and between AIx and height significant in
both sexes, but more pronounced in females (Fig. 1c, d).
The negative correlation between AIx and HR was
modest but statistically significant (Fig. 1e, f ). AIx
showed a strong association with SVRI in males, while
in females the association was somewhat less marked
(Fig. 2a, b). The association between AIx and the com-
mon logarithm of PWV was corresponding in both sexes
(Fig. 2c, d). As expected, age showed a strong correlation
with PWV (Fig. 2e, f ).
AIx and weight showed no statistically significant cor-
relation (Fig. 3a, b). SVI was not associated with AIx in
females, whereas in males a weak inverse association
Fig. 2 Associations between augmentation index and haemodynamic variables, and association between pulse wave velocity and age. Scatter
plots show associations between augmentation index and systemic vascular resistance index (a, b), the common logarithm of pulse wave velocity (c, d),
and association between pulse wave velocity and age (e, f) in male and female subjects, the lines depict mean and 95 % confidence intervals of mean
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was observed (r = -0.136, p = 0.033) (Fig. 3c, d). A Spear-
man’s correlation matrix for the haemodynamic variables
and age for both sexes is presented in the supplemental
material (Additional file 2).
Regression analyses on factors associated with AIx
In the first regression analyses using only haemodynamic
variables the results showed that, for both males and
females, SVRI (P < 0.001 for both), PWV (P < 0.001
for both), SVI (P = 0.001 for both) and HR (P = 0.049
for males and P = 0.036 for females) were significant
explanatory variables for AIx. The contributions of
the beta values of the variables (SVRI, the common
logarithm of PWV, HR and SVI) showed overlapping
confidence intervals in this model. The overall R2 of the
model was 0.381 in males and 0.317 in females (Table 3).
In the second regression model (Table 4), we used
SVR and stroke volume instead of the indexed versions
of these variables, as height and weight were also in-
cluded in the model. SVR, the common logarithm of
PWV, stroke volume, HR, age, height, weight, smoking
in pack years, plasma LDL cholesterol, triglyceride,
cystatin-C, and fasting glucose concentrations were used
as explanatory variables. In male subjects, age, SVR,
stroke volume and weight were significant explanatory
variables for AIx (R2 = 0.580). In female subjects, age,
SVR, height, stroke volume and smoking were the ex-
planatory variables for AIx (R2 = 0.621). Of note, PWV
was no more a significant explanatory variable for AIx in
this model, probably due to the high correlation of this
variable with age (Additional file 2).
As several haemodynamic variables showed correla-
tions with each other (Additional file 2), tests for col-
linearity were calculated in the regression models:
variance inflation factors (VIF) were assessed for SVR,
SVRI, and the common logarithm of PWV, the vari-
ables of interest. In all of the models, the VIF values
ranged 1.5–2.8, which does not indicate a marked
collinearity problem.
Recording of PWV with impedance cardiography versus
applanation tonometry
The basic characteristics of the additional 80 subjects
participating in this separate sub-study are presented in
the Additional file 3. The five most common self-reported
medical conditions were hypertension (n = 16), asthma
Fig. 3 Associations between augmentation index and weight (a, b) and stroke volume index (c, d). Scatter plots in male and female subjects, the
lines depict mean and 95 % confidence intervals of mean
Wilenius et al. BMC Cardiovascular Disorders  (2016) 16:131 Page 7 of 11
(n = 10), gastro-oesophageal reflux (n = 3), hypothyroidism
(n = 3) and osteoarthritis (n = 2). Thirteen subjects were
on BP-lowering medication. The mean carotid-femoral
PWV measured using applanation tonometry was
7.63 m/s, whereas the mean aortic-popliteal PWV using
impedance cardiography was 7.64 m/s. The bias
(PWV(impedance cardiography) – PWV(applanation
tonometry)) and precision (SD of differences) between
these two methods were 0.02 and 1.06 m/s, respectively,
and the correlation between these two methods was very
good (Fig. 4a, b).
Discussion
In the present study comprising a relatively large popu-
lation (n = 488), AIx was significantly associated with
peripheral vascular resistance in addition to PWV. As
stiffening of the arteries results in earlier wave reflection
and augmentation of central systolic pressure, AIx has
often been labelled as a direct marker of arterial stiffness
[13–19]. However, AIx is only an indirect measure of
arterial stiffness that provides information concerning
central wave reflections, whereas the determination of
carotid-femoral PWV remains the gold standard for the
evaluation of arterial stiffness [2, 20]. In order to deter-
mine the contribution of arterial stiffness to wave reflec-
tions, pulse wave analysis should be combined with the
measurement of large arterial PWV [2].
Since the reflected pressure waves to a significant pro-
portion originate from resistance arteries [1], SVR can
be expected to affect wave reflection and correlate with
the magnitude of AIx. The relative contributions of SVR
versus large arterial stiffness as determinants of AIx have
not been previously compared. In the present study,
SVRI was a significant haemodynamic determinant of
Table 3 Linear regression analysis with backward elimination: haemodynamic variables as explanatory variables for augmentation index
Augmentation index b beta 95 % Confidence interval of beta P value
Lower Upper
Male subjects, R2 = 0.381, p < 0.001
Systemic vascular resistance index 0.008 0.425 0.255 0.595 <0.001
Lg10 (pulse wave velocity) 47.384 0.409 0.275 0.543 <0.001
Stroke volume index 0.434 0.256 0.104 0.407 0.001
Heart rate -0.179 -0.150 -0.299 0.000 <0.049
Female subjects, R2 = 0.317, p < 0.001
Lg10 (pulse wave velocity) 55.253 0.400 0.275 0.541 <0.001
Systematic vascular resistance index 0.006 0.336 0.157 0.515 <0.001
Stroke volume index 0.434 0.278 0.114 0.442 0.001
Heart rate -0.199 -0.156 -0.303 -0.010 0.036
Variables used: Systematic vascular resistance index, the common logarithm of PWV, heart rate, stroke volume index. Lg10, the common logarithm
Table 4 Regression analysis for determinants of augmentation index
Augmentation index b beta 95 % Confidence interval of beta P value
Lower Upper
Male subjects, R2 = 0.580, p < 0.001
Age 0.563 0.577 0.460 0.671 <0.001
Systemic vascular resistance 0.018 0.437 0.354 0.631 <0.001
Stroke volume 0.160 0.185 0.068 0.314 0.003
Weight -0.129 -0.131 -0.270 -0.032 0.013
Female subjects, R2 = 0.621, p < 0.001
Age 0557 0.557 0.474 0.670 <0.001
Systemic vascular resistance 0.011 0.295 0.180 0.400 <0.001
Height -0.490 -0.255 -0.355 -0.161 <0.001
Stroke volume 0.154 0.177 0.067 0.302 0.002
Smoking 0.209 0.088 0.019 0.203 0.018
Linear regression analysis with backward elimination: haemodynamic variables, subject characteristics and laboratory values used as explanatory variables for
augmentation index. Variables used: Systemic vascular resistance, the common logarithm of pulse wave velocity, stroke volume, heart rate, age, height, weight,
smoking (in pack years); plasma LDL, triglyceride, cystatin-C and fasting glucose concentrations; LDL, low density lipoprotein
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AIx, but due to overlapping confidence intervals the dis-
tinct order of the haemodynamic variables defining AIx
cannot be stated (Table 3). In a regression model includ-
ing haemodynamic and demographic data, SVR was the
most significant haemodynamic determinant of AIx in
males, whereas SVR and stroke volume were the signifi-
cant haemodynamic determinants in females (Table 4).
Like in previous studies [9–11], age and height were sig-
nificantly related to AIx in both sexes. Although weight
was a significant explanatory variable of AIx, this might
rather be related subject height than adiposity, as the re-
lationship was inverse, corresponding to the correlation
between AIx and height in males (Fig. 1c). Of note,
PWV was not a significant explanatory variable for AIx
in the model that included several explanatory variables
(Table 4). This can be attributed to the strong correlation
between age and PWV (Fig. 2e, f ). Recently, higher AIx
was independently associated with greater media:lumen
ratio in small subcutaneous arteries of 67 hypertensive
subjects, while carotid-femoral PWV was not a significant
explanatory variable for AIx in multiple regression analysis
[32]. As remodelling of resistance arteries is an important
determinant of vascular resistance [33], these results
support the view of SVR as an important determinant
of central wave reflection.
In addition to SVRI and PWV, SVI was a significant
determinant of AIx in the regression analyses (Table 3).
This might be due to the higher blood volume entering the
aorta and the subsequent increase in the haemodynamic
load, since the pattern of ventricular ejection is known to
influence AIx [2]. Previous reports have also suggested that
AIx is not only a measure of reflected pressure waves, but
it also exhibits the properties of cardiac performance and
ventricular-vascular coupling [23, 34, 35]. Yet, we also
observed a weak inverse correlation between AIx and
SVI in males (Fig. 3c). This could possibly be explained by
the higher ejected blood volume increasing pressure at the
first inflection point of the aortic pressure wave without
affecting pressure at the second inflection point, the
mechanism of which could result in a reduction of the
augmented pressure.
Although the present results indicate that SVRI is sig-
nificantly associated with AIx, they show no causalities,
and a reverse connection could also be possible. In-
creased pulsatile pressure has been suggested to damage
the peripheral vasculature causing vascular remodelling
with a subsequent increase in arterial resistance [36].
We found a clear association between age and AIx (r =
0.646-0.67), and between age and PWV (r = 0.572-0.626),
but the association between AIx and PWV was less
marked (r = 0.361-0.376). Thus, age-related changes in
AIx cannot be entirely explained by increased arterial
stiffness, at least when stiffness is evaluated by measure-
ment of PWV. The present haemodynamic measurements
were continuous and data capture lasted for 3 min, and
the statistical analyses of each variable in individual sub-
jects were based on the mean of approximately 180–190
cardiac cycles. Many previous studies utilizing pulse wave
analysis have obtained haemodynamic values with a pen-
like tonometric sensor from 10 consecutive heart beats
[14], which is a more operator dependent method. The
aortic-popliteal impedance cardiography measurement
of PWV has been previously validated against aortic-
popliteal PWV measurements using Doppler ultrasound
[27]. Our present recordings in 80 subjects showed no
bias, and a very good correlation was observed between
the tonometric (carotid-femoral) and the impedance
cardiography (aortic-popliteal) measurements of PWV
(Fig. 4), although these recordings are not focused on
identical sections of the arterial tree. Finally, AIx is
not an ideal measure of wave reflections [6, 7, 37],
and additional studies that use wave separation to
Fig. 4 Comparison of two methods in the evaluation of large arterial
stiffness. Correlation between pulse wave velocity measured using
impedance cardiography and applanation tonometry, the lines depict
mean and 95 % confidence intervals of mean (a); and differences
between the two methods plotted against the average value of the
methods with limits of agreement (±2SD) shown (b)
Wilenius et al. BMC Cardiovascular Disorders  (2016) 16:131 Page 9 of 11
explore wave reflections are needed to corroborate
the present findings in the future.
Conclusions
We found that AIx was significantly determined by both
SVRI and PWV. However, SVR was a more significant
determinant in a model, where demographic, metabolic
and haemodynamic factors were comprehensively con-
sidered. The present results add up to the data showing
that AIx is a marker of central wave reflections, the
magnitude of which is influenced by arterial stiffness.
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